Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Giunti Psychometrics Holding SpAFRA:0ZD 13 ROA % is 4.45% as of Dec. 2025, which is 50% above its 10-year median of 2.97. GuruFocus rates FRA:0ZD with a GF Score™ of 13/100. Among 852 Medical Devices & Instruments companies, Giunti Psychometrics Holding SpA ranks better than 66.08% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Giunti Psychometrics Holding SpA's annualizedNet Income for the quarter that ended in Dec. 2025 was €1.60 Mil.
Giunti Psychometrics Holding SpA's average Total Assets over the quarter that ended in Dec. 2025 was €36.01 Mil. Therefore, Giunti Psychometrics Holding SpA's annualized ROA % for the quarter that ended in Dec. 2025 was 4.45%.
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is one times the annual (Dec. 2025) net income data. The Revenue data used here is one times the annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Giunti Psychometrics Holding SpA ROA % Related Terms
Giunti Psychometrics Holding SpA ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Giunti Psychometrics Holding SpA ROA % Chart
Giunti Psychometrics Holding SpA Annual Data
Trend
Dec24
Dec25
ROA %
1.49
4.45
Giunti Psychometrics Holding SpA Semi-Annual Data
Dec24
Dec25
ROA %
1.49
4.45
FRA:0ZD vs ABT, SYK, MDT: ROA % Comparison
For the Medical Devices subindustry, Giunti Psychometrics Holding SpA's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Giunti Psychometrics Holding SpA ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Giunti Psychometrics Holding SpA's ROA % distribution charts can be found below:
* The bar in red indicates where Giunti Psychometrics Holding SpA's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Giunti Psychometrics Holding SpA (FRA:0ZD) has a ROA % of 4.45% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Giunti Psychometrics Holding SpA and its competitors. This is 50% above median its historical median of 2.97. Over the past decade, Giunti Psychometrics Holding SpA's ROA % has ranged from 1.49 to 4.45. According to the industry distribution chart, Giunti Psychometrics Holding SpA ranks #289 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 33.9%.
Is Giunti Psychometrics Holding SpA's ROA % too high?
Giunti Psychometrics Holding SpA's current ROA % of 4.45% is 50% above median its 10-year median of 2.97. Over the past 10 years, this metric has ranged from a low of 1.49 to a high of 4.45. The Medical Devices & Instruments industry median ROA % is 0.70. Giunti Psychometrics Holding SpA's value of 4.45% is 535.7% above this industry median. Based on the distribution chart, Giunti Psychometrics Holding SpA ranks #289 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Giunti Psychometrics Holding SpA has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Giunti Psychometrics Holding SpA's ROA % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Giunti Psychometrics Holding SpA ranks #289 out of 852 companies for ROA %. This puts Giunti Psychometrics Holding SpA in the upper half of its industry. The industry median ROA % is 0.70. Giunti Psychometrics Holding SpA's value of 4.45% is 535.7% above this benchmark. Historically, Giunti Psychometrics Holding SpA's own ROA % has ranged from 1.49 to 4.45 over the past decade. While the company's 10-year median is 2.97 vs. the industry median of 0.70, Giunti Psychometrics Holding SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.70, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Giunti Psychometrics Holding SpA's current ROA % of 4.45% is 535.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Giunti Psychometrics Holding SpA and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Giunti Psychometrics Holding SpA's current ROA % is 4.45%, which is 50% above median its own 10-year median of 2.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giunti Psychometrics Holding SpA stock overvalued right now?
Giunti Psychometrics Holding SpA (FRA:0ZD) has a current ROA % of 4.45%. The current ROA % is 4.45%, which is 50% above median its 10-year median of 2.97 and 535.7% above the Medical Devices & Instruments industry median of 0.70. Giunti Psychometrics Holding SpA's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Giunti Psychometrics Holding SpA (FRA:0ZD), the current ROA % is 4.45% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Giunti Psychometrics Holding SpA operates internationally in the field of psychological assessment. The company designs, develops, and distributes tools and methodologies for psychologicaland psycho-aptitude assessment, used in various fields, including clinical practice (clinical and health psychology, child psychiatry and neuropsychiatry, neuropsychology and speech therapy), human resources management (work and organizational psychology), and education and guidance (level assessment tests, tools for diagnosing learning difficulties, and tools for school, university, and career guidance). The majority of revenue is derived from sales in the mental health and clinical area.
13GF Score
Get the complete analysis for FRA:0ZD
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0ZD has been successfully added to your 
